Aarti Drugs wins GST case as Supreme Court dismisses department's appeal
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Supreme Court has dismissed the Special Leave Petition filed by the GST Department against Aarti Drugs, upholding the Bombay High Court order that had set aside the CGST demand. The original dispute involved a Show Cause Notice alleging contravention of Rule 96(10) of CGST Rules with proposed IGST demand of Rs. 230.70 crore for FY 2017-18 to FY 2021-22. The CGST order had demanded Rs. 20.72 crore in IGST refund along with interest and a penalty of Rs. 20.72 crore. The company has confirmed there is no financial, operational, or other impact as the matter stands disposed of in its favor.
Positive outcome. The Rs. 20.72 crore IGST refund demand and equal penalty stand quashed. No financial impact on the company.